Invivyd (IVVD) Cash & Equivalents (2020 - 2025)

Invivyd has reported Cash & Equivalents for 6 years, with the latest figure at $226.7 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 226.88% year-over-year to $226.7 million; the trailing twelve-month figure through Dec 2025 stood at $226.7 million (up 226.88% YoY), and the FY2025 full-year result was $226.7 million, up 226.88% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $226.7 million, up from $85.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $542.2 million in Q4 2021, with the low at $34.9 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $227.9 million across 5 years, with a median of $181.8 million in 2023.
• Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 371.55% — and 2022, when it plunged 83.02%.
• Invivyd's Cash & Equivalents stood at $542.2 million in 2021, then sank by 83.02% to $92.1 million in 2022, then soared by 117.91% to $200.6 million in 2023, then slumped by 65.44% to $69.3 million in 2024, then surged by 226.88% to $226.7 million in 2025.
• The last three Cash & Equivalents figures came in at $226.7 million (Q4 2025), $85.0 million (Q3 2025), and $34.9 million (Q2 2025), per Business Quant data.